Radiopharm Theranostics Limited
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2022 | — | $63.0M | $27.0M |
| FY2023 | — | $45.6M | $11.7M |
| FY2024 | — | $27.4M | $18.6M |
| FY2025 | — | $42.9M | $29.1M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2022 | — | $63.0M | $27.0M |
| FY2023 | — | $45.6M | $11.7M |
| FY2024 | — | $27.4M | $18.6M |
| FY2025 | — | $42.9M | $29.1M |